- Home
- GOSS vs PHLT Comparison
GOSS vs PHLT Comparison
Compare GOSS & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PHLT
- Stock Information
- Founded
- GOSS 2015
- PHLT 1976
- Country
- GOSS United States
- PHLT United States
- Employees
- GOSS N/A
- PHLT N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PHLT Other Consumer Services
- Sector
- GOSS Health Care
- PHLT Consumer Discretionary
- Exchange
- GOSS Nasdaq
- PHLT Nasdaq
- Market Cap
- GOSS 586.6M
- PHLT 601.2M
- IPO Year
- GOSS 2019
- PHLT N/A
- Fundamental
- Price
- GOSS $3.08
- PHLT $7.70
- Analyst Decision
- GOSS Strong Buy
- PHLT Buy
- Analyst Count
- GOSS 6
- PHLT 2
- Target Price
- GOSS $8.60
- PHLT $7.88
- AVG Volume (30 Days)
- GOSS 4.8M
- PHLT 969.8K
- Earning Date
- GOSS 11-06-2025
- PHLT 11-05-2025
- Dividend Yield
- GOSS N/A
- PHLT N/A
- EPS Growth
- GOSS N/A
- PHLT N/A
- EPS
- GOSS N/A
- PHLT N/A
- Revenue
- GOSS $40,237,000.00
- PHLT $137,357,000.00
- Revenue This Year
- GOSS N/A
- PHLT $12.38
- Revenue Next Year
- GOSS $34.10
- PHLT $10.09
- P/E Ratio
- GOSS N/A
- PHLT N/A
- Revenue Growth
- GOSS N/A
- PHLT 15.21
- 52 Week Low
- GOSS $0.66
- PHLT $2.17
- 52 Week High
- GOSS $3.60
- PHLT $7.74
- Technical
- Relative Strength Index (RSI)
- GOSS 61.72
- PHLT 81.35
- Support Level
- GOSS $2.93
- PHLT $7.56
- Resistance Level
- GOSS $3.37
- PHLT $7.67
- Average True Range (ATR)
- GOSS 0.29
- PHLT 0.03
- MACD
- GOSS 0.01
- PHLT -0.10
- Stochastic Oscillator
- GOSS 57.55
- PHLT 100.00
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.